Sirtex Medical Limited Launches New Global Website for SIR-Spheres® Microspheres - A Form of Selective Internal Radiation Therapy (SIRT) for Liver Tumours

Sirtex Medical Limited Launches New Global Website for SIR-Spheres® Microspheres - A Form of Selective Internal Radiation Therapy (SIRT) for Liver Tumours PR Newswire SYDNEY, December 11, 2012 SYDNEY, December 11, 2012 /PRNewswire/ -- http://www.sirtex.com informs doctors, patients and investors about the world's most widely used and widely studied form of SIRT for all cancers in the liver Sirtex today unveiled http://www.sirtex.com, a new, comprehensive and easy-to-use global website for doctors, nurses, patients and investors interested in learning more about SIR-Spheres microspheres, a form of radiotherapy targeting liver tumours that is gaining increasingly wide acceptance worldwide. "We faced some interesting challenges to make this website genuinely helpful to the wide range of people who might visit it," said Gilman Wong, Chief Executive Officer of Sirtex Medical Limited. "For example, administering SIR-Spheres microspheres to patients requires the skills of a team of doctors and nurses from medical oncology, hepatology, gastroenterology, liver surgery, interventional radiology, nuclear medicine and radiation oncology. Each discipline is critical to meeting the needs of a patient with liver tumours, but all have different perspectives and informational needs relative to SIR-Spheres microspheres," he explained. "The same holds true of patients.